Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities
- PMID: 10933393
- DOI: 10.1016/s1074-7613(00)00006-6
Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities
Abstract
All rearranging antigen receptor genes have one or two highly diverse complementarity determining regions (CDRs) among the six that typically form the ligand binding surface. We report here that, in the case of antibodies, diversity at one of these regions, CDR3 of the V(H) domain, is sufficient to permit otherwise identical IgM molecules to distinguish between a variety of hapten and protein antigens. Furthermore, we find that somatic mutation can allow such antibodies to achieve surprisingly high affinities. These results are consistent with a model in which the highly diverse CDR3 loops are the key determinant of specificity in antigen recognition in both T cell receptors (TCR) and antibodies, whereas the germline-encoded CDR1 and CDR2 sequences are much more cross-reactive.
Similar articles
-
Somatic diversity of the immunoglobulin repertoire is controlled in an isotype-specific manner.Eur J Immunol. 2001 Aug;31(8):2319-30. doi: 10.1002/1521-4141(200108)31:8<2319::aid-immu2319>3.0.co;2-t. Eur J Immunol. 2001. PMID: 11477544
-
The J558 VH CDR3 region contributes little to antibody avidity; however, it is the recognition element for cognate T cell control of the alpha(1-->3) dextran-specific antibody response.Int Immunol. 1998 Dec;10(12):1931-42. doi: 10.1093/intimm/10.12.1931. Int Immunol. 1998. PMID: 9885915
-
Rearrangement of the human heavy chain variable region gene V3-23 in transgenic mice generates antibodies reactive with a range of antigens on the basis of VHCDR3 and residues intrinsic to the heavy chain variable region.Clin Exp Immunol. 2001 Jan;123(1):1-8. doi: 10.1046/j.1365-2249.2001.01380.x. Clin Exp Immunol. 2001. PMID: 11167990 Free PMC article.
-
The evolutionary and structural 'logic' of antigen receptor diversity.Semin Immunol. 2004 Aug;16(4):239-43. doi: 10.1016/j.smim.2004.08.003. Semin Immunol. 2004. PMID: 15522622 Review.
-
Syngeneic antiidiotypic immune responses to a B cell lymphoma. Comparison between heavy chain hypervariable region peptides and intact Ig as immunogens.J Exp Med. 1985 Jul 1;162(1):19-34. doi: 10.1084/jem.162.1.19. J Exp Med. 1985. PMID: 3925067 Free PMC article. Review.
Cited by
-
An in vivo method for diversifying the functions of therapeutic antibodies.Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):e2025596118. doi: 10.1073/pnas.2025596118. Proc Natl Acad Sci U S A. 2021. PMID: 33658386 Free PMC article.
-
Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models.J Transl Med. 2015 Jun 6;13:185. doi: 10.1186/s12967-015-0539-4. J Transl Med. 2015. PMID: 26048777 Free PMC article.
-
Somatic hypermutation analysis for improved identification of B cell clonal families from next-generation sequencing data.PLoS Comput Biol. 2020 Jun 23;16(6):e1007977. doi: 10.1371/journal.pcbi.1007977. eCollection 2020 Jun. PLoS Comput Biol. 2020. PMID: 32574157 Free PMC article.
-
Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs.MAbs. 2022 Jan-Dec;14(1):2115200. doi: 10.1080/19420862.2022.2115200. MAbs. 2022. PMID: 36068722 Free PMC article.
-
Delta Inulin Adjuvant Enhances Plasmablast Generation, Expression of Activation-Induced Cytidine Deaminase and B-Cell Affinity Maturation in Human Subjects Receiving Seasonal Influenza Vaccine.PLoS One. 2015 Jul 15;10(7):e0132003. doi: 10.1371/journal.pone.0132003. eCollection 2015. PLoS One. 2015. PMID: 26177480 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
